Site Map

Information for Healthcare Providers

Healthcare Providers Home

REVLIMID^® for Multiple Myeloma

Clinical Trial Design

Efficacy in Multiple Myeloma

WARNINGS and Adverse Events

Dosing and Administration

REVLIMID^® for Myelodysplastic Syndromes

Deletion 5q in MDS

Dosing and Administration

Clinical Trial Design

WARNINGS and Adverse Events

Efficacy: Transfusion Independence

RevAssist^®

RevAssist^® for Prescribers

RevAssist^® for Patients

Patient Support Coordinator^®

Multiple Myeloma Topics

Multiple Myeloma Home

What Is REVLIMID^®?

REVLIMID^® Results

Prescription Process

RevAssist^®

Important Risk Information

How to Take REVLIMID^®

Understanding Side Effects

Blood Clots

Low Blood Counts

Gastrointestinal Disorders

Other Side Effects

Patient Support Coordinator^®

About Multiple Myeloma

Who Gets Multiple Myeloma?

Symptoms of Multiple Myeloma

Multiple Myeloma Glossary

Resources for Patients

Patient Medication Guide

Myelodysplastic Syndromes Topics

Myelodysplastic Syndromes Home

What Is REVLIMID^®?

RevAssist^®

Important Risk Information

How to Take REVLIMID^®

Understanding Side Effects

Low Blood Counts

Gastrointestinal Disorders

Skin Disorders

Dizziness and Headaches

Other Possible Side Effects

Patient Support Coordinator^®

About MDS

Types of MDS

Causes and Symptoms

Diagnosis and Prognosis

Treatment Options

Drug Therapy

Bone Marrow Transplantation

Transfusions

Lifestyle Modifications

Resources

Patient Medication Guide

	© 2005, Celgene Corporation, www.celgene.com This web site is intended for residents of the United States only. Privacy Policy | Terms of Use